Showing 121 - 140 results of 3,759 for search '(( decrease co infection ) OR ( ((decrease hiv) OR (decreased hiv)) infection ))', query time: 0.53s Refine Results
  1. 121
  2. 122
  3. 123

    Characteristics of TB patients with TBCD. by Peter D. Jackson (16014878)

    Published 2023
    “…There was no difference in demographics, HIV co-infection, socioeconomic status, or distance to TB clinic between TBCD and non-TBCD groups or within TBCD by time-period. …”
  4. 124

    De-identified data set. by Peter D. Jackson (16014878)

    Published 2023
    “…There was no difference in demographics, HIV co-infection, socioeconomic status, or distance to TB clinic between TBCD and non-TBCD groups or within TBCD by time-period. …”
  5. 125
  6. 126

    Image_1_Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis.tif by Shi Zou (12516892)

    Published 2022
    “…</p>Methods<p>The phenotypic and functional properties of peripheral blood γδ T cells in patients with HIV/TB co-infection were analyzed compared to healthy controls and patients with HIV mono-infection or TB by direct intracellular cytokine staining (ICS).…”
  7. 127

    Effect of free health insurance on HIV incidence. by Aurélia Lépine (637511)

    Published 2024
    Subjects: “…sexually transmitted infection…”
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137

    Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4<sup>+</sup> T lymphocytes by Sandra M. Gonzalez (7423307)

    Published 2019
    “…Considering this, we examined the <i>in vitro</i> effect of the treatment of peripheral blood mononuclear cells (PBMCs) with the active form of VitD, calcitriol, on cellular activation, function and susceptibility of CD4<sup>+</sup> T cells to HIV-1 infection.</p><p>Methods</p><p>We treated PBMCs from healthy HIV unexposed individuals (Co-HC) and frequently exposed, HIV-1 seronegative individuals (HESNs) from Colombia and from healthy non-exposed individuals from Canada (Ca-HC) with calcitriol and performed <i>in vitro</i> HIV-1 infection assays using X4- and R5-tropic HIV-1 strains respectively. …”
  18. 138
  19. 139
  20. 140